Cargando…

The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model

BACKGROUND: Clinical and experimental studies have pointed to the possible involvement of the transient receptor potential ankyrin type-1 (TRPA1) channels in migraine pain. In this study, we aimed to further investigate the role of these channels in an animal model of migraine using a novel TRPA1 an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demartini, Chiara, Tassorelli, Cristina, Zanaboni, Anna Maria, Tonsi, Germana, Francesconi, Oscar, Nativi, Cristina, Greco, Rosaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589714/ https://www.ncbi.nlm.nih.gov/pubmed/28884307 http://dx.doi.org/10.1186/s10194-017-0804-4

Ejemplares similares

Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model
por: Demartini, Chiara, et al.
Publicado: (2018)

Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine
por: Demartini, Chiara, et al.
Publicado: (2022)

Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine
por: Greco, Rosaria, et al.
Publicado: (2021)

Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine
por: Greco, Rosaria, et al.
Publicado: (2022)

Endocannabinoid System and Migraine Pain: An Update
por: Greco, Rosaria, et al.
Publicado: (2018)

New natural agonists of the transient receptor potential Ankyrin 1 (TRPA1) channel
por: Legrand, Coline, et al.
Publicado: (2020)

Transient Receptor Potential Ankyrin 1 (TRPA1) Channel and Neurogenic Inflammation in Pathogenesis of Asthma
por: Yang, Hang, et al.
Publicado: (2016)

Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine
por: Greco, Rosaria, et al.
Publicado: (2015)

Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
por: Greco, Rosaria, et al.
Publicado: (2020)

Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing
por: Greco, Rosaria, et al.
Publicado: (2018)

Expression and distribution of the transient receptor potential cationic channel ankyrin 1 (TRPA1) in the human seminal vesicles
por: Rahardjo, Harrina E., et al.
Publicado: (2022)

Transient Receptor Potential Ankyrin 1 (TRPA1) Channel as a Sensor of Oxidative Stress in Cancer Cells
por: Moccia, Francesco, et al.
Publicado: (2023)

Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings
por: Demartini, Chiara, et al.
Publicado: (2023)

Transient Receptor Potential Ankyrin 1 (TRPA1) Channel Mediates Acrolein Cytotoxicity in Human Lung Cancer Cells
por: Sakamoto, Akihiko, et al.
Publicado: (2023)

Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine
por: Greco, Rosaria, et al.
Publicado: (2022)

Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Niosomal Formulation of a Lipoyl-Carnosine Derivative Targeting TRPA1 Channels in Brain
por: Maestrelli, Francesca, et al.
Publicado: (2019)

Correction: Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Transgenic Chlamydomonas Expressing Human Transient Receptor Potential Ankyrin 1 (TRPA1) Channels to Assess the Effect of Agonists and Antagonists
por: Yoshida, Megumi, et al.
Publicado: (2020)

Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis
por: Corrado, Michele, et al.
Publicado: (2022)

Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice
por: Horváth, Ádám, et al.
Publicado: (2016)

TRPA1 and other TRP channels in migraine
por: Benemei, Silvia, et al.
Publicado: (2013)

Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human osteoarthritic chondrocytes
por: Nummenmaa, Elina, et al.
Publicado: (2016)

Transient Receptor Potential Ankyrin 1 (TRPA1) Methylation and Chronic Pain: A Systematic Review
por: Celsi, Fulvio, et al.
Publicado: (2023)

URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia
por: Demartini, Chiara, et al.
Publicado: (2023)

Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks
por: De Icco, Roberto, et al.
Publicado: (2021)

Transient Receptor Potential Ankyrin 1 (TRPA1)—An Inflammation-Induced Factor in Human HaCaT Keratinocytes
por: Luostarinen, Samu, et al.
Publicado: (2021)

Effects of anandamide in migraine: data from an animal model
por: Greco, Rosaria, et al.
Publicado: (2011)

Species-specific pharmacology of Trichloro(sulfanyl)ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonists
por: Klionsky, Lana, et al.
Publicado: (2007)

Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod‐induced, psoriasiform dermal inflammation in mice
por: Zhou, Yan, et al.
Publicado: (2019)

Transient Receptor Potential Ankyrin 1 (TRPA1) Is Involved in Upregulating Interleukin-6 Expression in Osteoarthritic Chondrocyte Models
por: Nummenmaa, Elina, et al.
Publicado: (2020)

A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain
por: Nativi, Cristina, et al.
Publicado: (2013)

Unique Responses are Observed in Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and TRPV1) Co-Expressing Cells
por: Sadofsky, Laura R., et al.
Publicado: (2014)

Transient receptor potential ankyrin 1 (TRPA1) plays a critical role in a mouse model of cancer pain
por: Antoniazzi, Caren Tatiane De David, et al.
Publicado: (2018)

Lack of transient receptor potential ankyrin 1 (TRPA1) retards cutaneous wound healing in mice: A preliminary study
por: Murata, Shizumasa, et al.
Publicado: (2022)

Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model
por: Greco, Rosaria, et al.
Publicado: (2014)

P007. Inhibition of monoacylglycerol lipase activity modulates the activation of brain structures relevant for migraine pathogenesis
por: Greco, Rosaria, et al.
Publicado: (2015)

Expression of Transient Receptor Potential Ankyrin 1 (TRPA1) and Its Role in Insulin Release from Rat Pancreatic Beta Cells
por: Cao, De-Shou, et al.
Publicado: (2012)

Discovery of BAY-390, a Selective CNS Penetrant Chemical Probe as Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonist
por: Mesch, Stefanie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m5n2ikba4g753vsuv3445i6gs5